ClinVar Miner

Submissions for variant NM_000048.4(ASL):c.556C>T (p.Arg186Trp)

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 5
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Women's Health and Genetics/Laboratory Corporation of America, LabCorp RCV001358697 SCV001554511 pathogenic Argininosuccinate lyase deficiency 2021-03-19 criteria provided, single submitter clinical testing Variant summary: ASL c.556C>T (p.Arg186Trp) results in a non-conservative amino acid change located in the Fumarate lyase, N-terminal domain (IPR022761) of the encoded protein sequence. Five of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 9e-06 in 221462 control chromosomes (gnomAD). c.556C>T has been reported in the literature in multiple individuals (both homozygous and compound heterozygous) affected with Argininosuccinic Aciduria (example: Imtiaz_2010, Balmer_2014). These data indicate that the variant is very likely to be associated with disease. Very low enzymatic activity (% of wild type control) was found in a patient derived sample who was compound heterozygous for the variant of interest and another splice site variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014. Based on the evidence outlined above, the variant was classified as pathogenic.
Invitae RCV001358697 SCV001585628 pathogenic Argininosuccinate lyase deficiency 2021-12-03 criteria provided, single submitter clinical testing This sequence change replaces arginine, which is basic and polar, with tryptophan, which is neutral and slightly polar, at codon 186 of the ASL protein (p.Arg186Trp). The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. This missense change has been observed in individual(s) with argininosuccinic aciduria (PMID: 20298553, 29326055, 31709144). ClinVar contains an entry for this variant (Variation ID: 1050820). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt ASL protein function. This variant disrupts the p.Arg186 amino acid residue in ASL. Other variant(s) that disrupt this residue have been determined to be pathogenic (Invitae). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic.
Genetic Services Laboratory,University of Chicago RCV001820057 SCV002064506 likely pathogenic not provided 2017-08-18 criteria provided, single submitter clinical testing
Victorian Clinical Genetics Services,Murdoch Childrens Research Institute RCV001358697 SCV002557748 pathogenic Argininosuccinate lyase deficiency 2022-02-02 criteria provided, single submitter clinical testing Based on the classification scheme VCGS_Germline_v1.3.4, this variant is classified as Pathogenic. Following criteria are met: 0102 - Loss of function is a known mechanism of disease in this gene and is associated with argininosuccinic aciduria (MIM#207900). (I) 0106 - This gene is associated with autosomal recessive disease. (I) 0200 - Variant is predicted to result in a missense amino acid change from arginine to tryptophan. (I) 0251 - This variant is heterozygous. (I) 0304 - Variant is present in gnomAD <0.01 for a recessive condition (v2: 2 heterozygotes, 0 homozygotes). (SP) 0309 - An alternative amino acid change at the same position has been observed in gnomAD (v2: 4 heterozygotes, 0 homozygotes). (I) 0501 - Missense variant consistently predicted to be damaging by multiple in silico tools or highly conserved with a major amino acid change. (SP) 0600 - Variant is located in the annotated lyase 1 domain (DECIPHER). (I) 0704 - Another missense variant comparable to the one identified in this case has limited previous evidence for pathogenicity. The p.(Arg186Gln) variant has been reported as pathogenic (ClinVar) and fibroblasts of a compound heterozygote patient showed a reduction of less than 2% of activity compared to wild type (PMID: 17326097). (SP) 0801 - This variant has strong previous evidence of pathogenicity in unrelated individuals. It has been reported in multiple homozygous and compound heterozygous individuals with argininosuccinic aciduria (ClinVar, PMIDs: 20298553, 31709144). (SP) 1208 - Inheritance information for this variant is not currently available in this individual. (I) Legend: (SP) - Supporting pathogenic, (I) - Information, (SB) - Supporting benign
Natera, Inc. RCV001358697 SCV002076015 pathogenic Argininosuccinate lyase deficiency 2020-05-15 no assertion criteria provided clinical testing

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.